{
  "hypothesis": "h206",
  "title": "Missing DRKG Drugs Analysis",
  "summary": {
    "total_gt_drugs": 2367,
    "drugs_with_embeddings": 1480,
    "drugs_without_embeddings": 887,
    "biologics_missing": 40,
    "total_blocked_pairs": 2429,
    "biologic_blocked_pairs": 75
  },
  "missing_biologics_top_20": [
    {
      "drug": "CERTOLIZUMAB",
      "n_indications": 6,
      "indications": [
        "rheumatoid arthritis",
        "ankylosing spondylitis",
        "psoriatic arthritis",
        "Chronic small plaque psoriasis",
        "pustular psoriasis",
        "Erythrodermic psoriasis"
      ]
    },
    {
      "drug": "Faricimab",
      "n_indications": 5,
      "indications": [
        "wet macular degeneration",
        "diabetic macular edema",
        "age-related macular degeneration",
        "Macular Edema",
        "retinal vein occlusion"
      ]
    },
    {
      "drug": "Epcoritamab",
      "n_indications": 4,
      "indications": [
        "diffuse large B-cell lymphoma",
        "relapsed/refractory diffuse large B-cell lymphoma",
        "primary mediastinal large B-cell lymphoma",
        "follicular lymphoma"
      ]
    },
    {
      "drug": "Sutimlimab",
      "n_indications": 3,
      "indications": [
        "cold agglutinin disease",
        "Hemolysis",
        "hemolytic anemia"
      ]
    },
    {
      "drug": "Inotuzumab ozogamicin only product",
      "n_indications": 3,
      "indications": [
        "acute lymphoblastic leukemia",
        "precursor B-cell acute lymphoblastic leukemia",
        "B-cell acute lymphoblastic leukemia"
      ]
    },
    {
      "drug": "Soravtansine",
      "n_indications": 3,
      "indications": [
        "ovarian carcinoma",
        "fallopian tube cancer",
        "Primary Peritoneal Cancer"
      ]
    },
    {
      "drug": "Tislelizumab",
      "n_indications": 3,
      "indications": [
        "esophageal squamous cell carcinoma",
        "gastric cancer",
        "gastroesophageal junction adenocarcinoma"
      ]
    },
    {
      "drug": "Gemtuzumab",
      "n_indications": 3,
      "indications": [
        "acute myeloid leukemia",
        "acute promyelocytic leukemia",
        "Relapsing acute myeloid leukemia"
      ]
    },
    {
      "drug": "Tilmanocept",
      "n_indications": 3,
      "indications": [
        "breast cancer",
        "melanoma",
        "oral cavity squamous cell carcinoma"
      ]
    },
    {
      "drug": "Elranatamab",
      "n_indications": 2,
      "indications": [
        "Relapse multiple myeloma",
        "plasma cell myeloma"
      ]
    },
    {
      "drug": "Teclistamab",
      "n_indications": 2,
      "indications": [
        "Relapse multiple myeloma",
        "plasma cell myeloma"
      ]
    },
    {
      "drug": "marstacimab",
      "n_indications": 2,
      "indications": [
        "hemophilia A",
        "hemophilia B"
      ]
    },
    {
      "drug": "Amivantamab",
      "n_indications": 2,
      "indications": [
        "EGFR-related lung cancer",
        "non-small cell lung carcinoma"
      ]
    },
    {
      "drug": "Mirikizumab",
      "n_indications": 2,
      "indications": [
        "ulcerative colitis",
        "Crohn disease"
      ]
    },
    {
      "drug": "Nipocalimab",
      "n_indications": 2,
      "indications": [
        "Generalized myasthenia",
        "myasthenia gravis"
      ]
    },
    {
      "drug": "Satralizumab",
      "n_indications": 2,
      "indications": [
        "neuromyelitis optica spectrum disorder with anti-AQP4 antibodies",
        "neuromyelitis optica"
      ]
    },
    {
      "drug": "Spesolimab",
      "n_indications": 2,
      "indications": [
        "generalized pustular psoriasis",
        "pustular psoriasis"
      ]
    },
    {
      "drug": "Glofitamab",
      "n_indications": 2,
      "indications": [
        "relapsed/refractory diffuse large B-cell lymphoma",
        "diffuse large B-cell lymphoma"
      ]
    },
    {
      "drug": "LONCASTUXIMAB",
      "n_indications": 2,
      "indications": [
        "diffuse large B-cell lymphoma",
        "high grade B-cell lymphoma"
      ]
    },
    {
      "drug": "Ibritumomab",
      "n_indications": 2,
      "indications": [
        "non-Hodgkin lymphoma",
        "mantle cell lymphoma"
      ]
    }
  ],
  "manual_rules": [
    {
      "drug_name": "CERTOLIZUMAB",
      "indications": [
        "rheumatoid arthritis",
        "ankylosing spondylitis",
        "psoriatic arthritis",
        "Chronic small plaque psoriasis",
        "pustular psoriasis",
        "Erythrodermic psoriasis"
      ],
      "n_indications": 6,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "Faricimab",
      "indications": [
        "wet macular degeneration",
        "diabetic macular edema",
        "age-related macular degeneration",
        "Macular Edema",
        "retinal vein occlusion"
      ],
      "n_indications": 5,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "Epcoritamab",
      "indications": [
        "diffuse large B-cell lymphoma",
        "relapsed/refractory diffuse large B-cell lymphoma",
        "primary mediastinal large B-cell lymphoma",
        "follicular lymphoma"
      ],
      "n_indications": 4,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "Sutimlimab",
      "indications": [
        "cold agglutinin disease",
        "Hemolysis",
        "hemolytic anemia"
      ],
      "n_indications": 3,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "Inotuzumab ozogamicin only product",
      "indications": [
        "acute lymphoblastic leukemia",
        "precursor B-cell acute lymphoblastic leukemia",
        "B-cell acute lymphoblastic leukemia"
      ],
      "n_indications": 3,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "Soravtansine",
      "indications": [
        "ovarian carcinoma",
        "fallopian tube cancer",
        "Primary Peritoneal Cancer"
      ],
      "n_indications": 3,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "Tislelizumab",
      "indications": [
        "esophageal squamous cell carcinoma",
        "gastric cancer",
        "gastroesophageal junction adenocarcinoma"
      ],
      "n_indications": 3,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "Gemtuzumab",
      "indications": [
        "acute myeloid leukemia",
        "acute promyelocytic leukemia",
        "Relapsing acute myeloid leukemia"
      ],
      "n_indications": 3,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "Tilmanocept",
      "indications": [
        "breast cancer",
        "melanoma",
        "oral cavity squamous cell carcinoma"
      ],
      "n_indications": 3,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "Elranatamab",
      "indications": [
        "Relapse multiple myeloma",
        "plasma cell myeloma"
      ],
      "n_indications": 2,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "Teclistamab",
      "indications": [
        "Relapse multiple myeloma",
        "plasma cell myeloma"
      ],
      "n_indications": 2,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "marstacimab",
      "indications": [
        "hemophilia A",
        "hemophilia B"
      ],
      "n_indications": 2,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "Amivantamab",
      "indications": [
        "EGFR-related lung cancer",
        "non-small cell lung carcinoma"
      ],
      "n_indications": 2,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "Mirikizumab",
      "indications": [
        "ulcerative colitis",
        "Crohn disease"
      ],
      "n_indications": 2,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "Nipocalimab",
      "indications": [
        "Generalized myasthenia",
        "myasthenia gravis"
      ],
      "n_indications": 2,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "Satralizumab",
      "indications": [
        "neuromyelitis optica spectrum disorder with anti-AQP4 antibodies",
        "neuromyelitis optica"
      ],
      "n_indications": 2,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "Spesolimab",
      "indications": [
        "generalized pustular psoriasis",
        "pustular psoriasis"
      ],
      "n_indications": 2,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "Glofitamab",
      "indications": [
        "relapsed/refractory diffuse large B-cell lymphoma",
        "diffuse large B-cell lymphoma"
      ],
      "n_indications": 2,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "LONCASTUXIMAB",
      "indications": [
        "diffuse large B-cell lymphoma",
        "high grade B-cell lymphoma"
      ],
      "n_indications": 2,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "Ibritumomab",
      "indications": [
        "non-Hodgkin lymphoma",
        "mantle cell lymphoma"
      ],
      "n_indications": 2,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "Pozelimab",
      "indications": [
        "diarrhea 10, protein-losing enteropathy type"
      ],
      "n_indications": 1,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "crovalimab",
      "indications": [
        "paroxysmal nocturnal hemoglobinuria"
      ],
      "n_indications": 1,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "Talquetamab",
      "indications": [
        "plasma cell myeloma"
      ],
      "n_indications": 1,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "donanemab",
      "indications": [
        "Alzheimer disease"
      ],
      "n_indications": 1,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "Tisotumab vedotin",
      "indications": [
        "cervical cancer"
      ],
      "n_indications": 1,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "zanidatamab",
      "indications": [
        "biliary tract cancer"
      ],
      "n_indications": 1,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "Nirsevimab",
      "indications": [
        "respiratory syncytial virus infectious disease"
      ],
      "n_indications": 1,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "Ansuvimab",
      "indications": [
        "Zaire Ebolavirus disease"
      ],
      "n_indications": 1,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "Gemtuzumab ozogamicin only product",
      "indications": [
        "acute myeloid leukemia"
      ],
      "n_indications": 1,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    },
    {
      "drug_name": "penpulimab",
      "indications": [
        "nasopharyngeal type undifferentiated carcinoma"
      ],
      "n_indications": 1,
      "rule_type": "manual_injection",
      "source": "every_cure_gt"
    }
  ],
  "suffix_counts": {
    "mab": 35,
    "ase": 4,
    "ADC": 1,
    "cept": 1
  }
}